Proteoglycans and Glycosaminoglycans

Dynamics of Bone and Cartilage Metabolism

Volumn , Issue , 2006, Pages 85-98

  Hardingham, Tim ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68749115617     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088562-6/50006-6     Document Type: Chapter

References (56)

1. Hardingham T.E., Fosang A.J. Proteoglycans: many forms, many functions. FASEB J. 1992, 6:861-870.
2. Fosang A.J., Hardingham T.E. Matrix proteoglycans. Extracellular Matrix 1996, Vol 2:200-229. Harwood Academic Publishers, Netherlands. W.D. Comper (Ed.).
3. Caterson B., Mahmoodian F., Sorrell J.M., Hardingham T.E., Bayliss M.T., Carney S.L., Ratcliffe A., Muir H. Modulation of native chondroitin sulphate structure in tissue development and in disease. J. Cell. Science 1990, 97:411-417.
4. Hazell P.K., Dent C., Fairclough J.A., Bayliss M.T., Hardingham T.E. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthr. Rheum. 1995, 38:953-959.
5. Calabro A., Benavides M., Tammi M., Hascall V., Midura R. Microanalysis of enzyme digests of hyaluronan and chondroitin/dematan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology 2000, 10:273-281.
6. Calabro A., Hascall V., Midura R. Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. Glycobiology 2000, 10:283-293.
7. Hardingham T.E. Articular cartilage. Oxford Textbook of Rheumatology 2004, 325-334. Oxford Medical Publications, Oxford, UK. 3rd Edition. D.A. Isenberg, P.J. Maddison, P. Wood, D.N. Glass, F.C. Breedfeld (Eds.).
8. Mow V.C., Hou J.S., Owens J.M., Ratcliffe A. Biphasic and quasilinear viscoelastic theories for hydrated soft tissues. Biomechanics of Diarthrodial Joints 1990, 215-260. Springer-Verlag, New York. V.C. Mow, A. Ratcliffe, S.L.-Y. Woo (Eds.).
9. Doege K.J., Coulter S.N., Meek L.m., Maslen K., Wood J.G. A human-specific polymorphism in the coding region of the aggrecan gene. Variable number of tandem repeats produce a range of core protein sizes in the general population. J. Biol. Chem. 1997, 272:13974-13979.
10. Spicer A.P., McDonald J.A. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J. Biol. Chem. 1998, 272:1923-1932.
11. Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A., Kubalak S., Klewe S.E., McDonald J.A. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 2000, 106:349-360.
12. Hardingham T.E., Muir H. The specific interaction of hyaluronic acid with cartilage proteoglycans. Biochim. Biophys. Acta 1972, 279:401-405.
13. Hardingham T.E. The role of link-protein in the structure of cartilage proteoglycans aggregates. Biochem. J. 1979, 177:237-247.
14. Kohda D., Morton C.J., Parkar A.A., Hatanaka H., Inagaki F.M., Campbell I.D., Day A.J. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 1996, 86:767-775.
15. Fosang A.J., Hardingham T.E. Isolation of the N-terminal globular domains from cartilage proteoglycan: identification of G2 domain and its lack of interaction with hyaluronate and link protein. Biochem. J. 1989, 261:801-809.
16. Hardingham T.E. Proteoglycans: their structure, interactions and molecular organization in cartilage. Biochem. Soc. Trans. 1981, 9:489-497.
17. Ratcliffe A., Hardingham T.E. Cartilage proteoglycan binding and link protein: radioimmunoassays and the detection of masked determinants in aggregates. Biochem. J. 1983, 213:371-378.
18. Spicer A.P., Joo A., Bowling R.A. A hyaluronan binding link protein gene family whose members are physically linked adjacent to chrondroitin sulfate proteoglycan core protein genes -The missing links. J. Biol. Chem. 2003, 278:21083-21091.
19. Shi S.L., Grothe S., Zhang Y.P., O'Connor-McCourt M.D., Poole A.R., Roughley P.J., Mort J.S. Link protein has greater affinity for versican than aggrecan. J. Biol. Chem. 2004, 279:12060-12066.
20. Czipri M., et al. Genetic rescue of chondrodysplasia and the perinatal lethal effect of cartilage link protein deficiency. J. Biol. Chem. 2003, 278:39214-39223.
21. Morgelin M., Paulsson M., Hardingham T.E., Heinegard D., Engel J. Cartilage proteoglycans: assembly with hyaluronate and link protein as studied by electron microscopy. Biochem. J. 1988, 253:175-185.
22. Morgelin M., Paulsson M., Heinegard D., Aebi U., Engel J. Evidence of a defined spatial arrangement of hyaluronan in the central filament of cartilage proteoglycan aggregates. Biochem. J. 1995, 307:595-601.
23. Nagase H., Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res. Ther. 2003, 5:94-103.
24. Hardingham T.E., Bayliss M.T. Proteoglycans of articular cartilage: changes in ageing and joint disease. Semin. Arthritis Rheum. 1990, 20:12-33.
25. Vertel B.M., Walters L.M., Grier B., Maine N., Goetinck P.F. Nanomelic chondrocytes synthesize, but fail to translocate, a truncated aggrecan precursor. J. Cell. Science 1993, 104:939-948.
26. Asberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D., Schachner M., Ruoslahti E., Yamaguchi Y. The C-type lectin domains, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc. Natl. Acad. Sci. USA 1997, 94:10116-10121.
27. Day J.M., Olin A.I., Murdoch A.D., Canfield A., Sasaki T., Timpl R., Hardingham T.E., Aspberg A. Alternative splicing of aggrecan G3 domain influences interactions with tenascin-C and other extracellular matrix proteins. J. Biol. Chem. 2004, 279:12511-12518.
28. Dudhia J., Davidson C.M., Wells T.M., Vynios D.H., Hardingham T.E., Bayliss M.T. Age related changes in the content of the carboxy-terminal region of aggrecan in human articular cartilage. Biochem. J. 1996, 313:933-940.
29. Doege K.J., Sasaki M., Horigan E., Hassell J.R., Yamada Y. Complete coding sequence and deduced primary structure of the human large aggregating proteoglycan, aggrecan. Human specific repeats and alternatively spliced forms. J. Biol. Chem. 1991, 266:894-902.
30. Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cell growth. Crit. Rev. Biochem. Mol. Biol. 1997, 32:141-174.
31. Kobe B., Deisenhofer J. A structural basis for the interactions between leucine-rich repeats and protein ligands. Nature (London) 1995, 374:183-186.
32. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy and comeal diseases. Glycobiology 2002, 12:107R-116R.
33. Fisher L.W., Termine J.D., Young M.F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several non-connective tissue proteins in a variety of species. J. Biol. Chem. 1989, 264:4571-4576.
34. Bianco P., Riminucci M., Young M.F., Termine J.D., Robey P.G. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 1990, 38:1549-1563.
35. Pringle G.A., Dodd C.M. Immunoelectron microscopic localization of the core protein of decorin near the d and e bands of tendon collagen fibrils by the use of monoclonal antibodies. J. Histochem. Cytochem. 1990, 38:1405-1411.
36. Hedbom H., Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J. Biol. Chem. 1993, 268:27307-27312.
37. Weber I.T., Harrison R.W., Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J. Biol. Chem. 1997, 271:31767-31770.
38. Scott P.G., Grossmann J.G., Dodd C.M., Sheehan J.K., Bishop P.N. Light and X-ray scattering show decorin to be a dimer in solution. J. Biol. Chem. 2003, 278:18353-18359.
39. Scott P.G., McEwan P.A., Dodd C.M., Bergmann E.M., Bishop P.N., Bella J. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteolycan. Proc. Natl Acad. Sci. 2004, 101:15633-15638.
40. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targetted disruption of decorin leads to abnormal collegen morphology and skin fragility. J. Cell. Biol. 1997, 136:729-743.
41. Ameye L., Aria D., Jepsen K., Oldberg A., Xu T., Young M. Abnormal collagen fibrils in tendons of biglycan/fibromodulin deficient mice lead to gait impairment, ectopic ossification and osteoarthritis. FASEB J. 2002, 16:673-680.
42. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor ?. Biochem. J. 1994, 302:527-534.
43. Tukeuchi Y., Kodama Y., Matsumoto T. Bone matrix decorin binds transforming growth factor-b and enhances its bioactivity. J. Biol. Chem. 1994, 269:32634-32638.
44. Hausser H., Groning A., Haslik A., Schonherr E., Kresse H. Selective inactivity of TGF-?/decorin complexes. FEBS Lett. 1994, 353:243-245.
45. Roughly P.J., Melching L.I., Recklies A.D. Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-?. Matrix. Biol. 1994, 14:51-59.
46. Plaas A.H.K., Neame P.J., Nivens C.M., Reiss L. Identification of the keratan sulfate attachment sites on bovine fibromodulin. J. Biol. Chem. 1990, 265:20634-20640.
47. Ezura Y., Chakravarti S., Oldberg A., Chervonea L., Birk D.E. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell Biol. 2000, 151:779-787.
48. Sampaio L.de O., Bayliss M.T., Hardingham T.E., Muir H. Dermatan sulphate proteoglycan from human articular cartilage. Biochem. J. 1988, 254:757-764.
49. Johnstone B., Markopoulos M., Neame P., Caterson B. Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. Biochem. J.292, 662-666.
50. Iozzo R.V., Cohen I.R., Grassel S., Murdoch A.D. The biology of perlecan: the multifacted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 1994, 302:625-639.
51. Iozzo R.V., Murdoch A.D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 1996, 10:598-614.
52. Costell M., Gustafsson E., Aszodi A., Morgelin M., Bloch W., Hunziker E., Addicks K., Timpl R., Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 1999, 147:1109-1122.
53. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., Yamada Y. Perlecan is essential for cartilage and cephalic development. Nature Genet. 1999, 23:354-358.
54. Nicole S., Davoine C-S., Topaloglu H., Cattolico L., Barral D., Beighton P., Ben Hamida C., Hammouda H., Cruaud C., White P.S., Samson D., Urtizberea J.A., Lehmann-Horn F., Weissenbach J., Hentati F., Fontaine B. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nature Genet. 2000, 26:480-483.
55. French M.M., Smith S.E., Akanbi K., Sanford T., Hecht J., Farach-Carson M.C., Carson D.D. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J. Cell Biol. 1999, 145:1103-1115.
56. Mongiat M., Fu J., Oldershaw R., Greenhalgh R., Gown A.M., Iozzo R.V. Perlecan protein interacts with extracellular matrix protein 1 (ECM1) a glycoprotein involved in bone formation and angiogenesis. J. Biol. Chem. 2003, 278:17491-17499.